[ad_1] Kalytera Therapeutics (TSXV: KALY) ANALYSIS OF PERFORMANCES IN FOCUS: PROFITABILITY REPORT: Monitoring of profitability control, company profit margin recorded at 0.00% and operating margin at 0.00%. The Company was able to maintain the return on the asset (ROA) at -10.04% in the last twelve months. Return on equity (ROE) …
Read More »KALY) – Bitcoin & Official Archive
